Foghorn Gross Profit Margin vs Non Current Liabilities Total Analysis

FHTX Stock  USD 7.62  0.41  5.11%   
Foghorn Therapeutics financial indicator trend analysis is much more than just examining Foghorn Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Foghorn Therapeutics is a good investment. Please check the relationship between Foghorn Therapeutics Gross Profit Margin and its Non Current Liabilities Total accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Foghorn Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Foghorn Stock please use our How to Invest in Foghorn Therapeutics guide.

Gross Profit Margin vs Non Current Liabilities Total

Gross Profit Margin vs Non Current Liabilities Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Foghorn Therapeutics Gross Profit Margin account and Non Current Liabilities Total. At this time, the significance of the direction appears to have strong relationship.
The correlation between Foghorn Therapeutics' Gross Profit Margin and Non Current Liabilities Total is 0.73. Overlapping area represents the amount of variation of Gross Profit Margin that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Foghorn Therapeutics, assuming nothing else is changed. The correlation between historical values of Foghorn Therapeutics' Gross Profit Margin and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit Margin of Foghorn Therapeutics are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Gross Profit Margin i.e., Foghorn Therapeutics' Gross Profit Margin and Non Current Liabilities Total go up and down completely randomly.

Correlation Coefficient

0.73
Relationship DirectionPositive 
Relationship StrengthSignificant

Gross Profit Margin

Non Current Liabilities Total

Most indicators from Foghorn Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Foghorn Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Foghorn Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Foghorn Stock please use our How to Invest in Foghorn Therapeutics guide.Selling General Administrative is likely to drop to about 19.7 M in 2024. Tax Provision is likely to drop to about 2.3 M in 2024
 2021 2022 2023 2024 (projected)
Depreciation And Amortization7.5M3.3M3.5M3.9M
Interest Income2.6M5.7M10.6M11.1M

Foghorn Therapeutics fundamental ratios Correlations

0.860.430.630.550.890.730.93-0.48-0.80.780.70.940.730.710.890.850.80.730.80.940.930.490.961.00.99
0.860.540.480.680.650.880.98-0.27-0.730.760.570.980.540.620.920.810.850.530.990.920.690.660.780.820.82
0.430.540.50.80.120.630.52-0.56-0.030.140.610.530.460.760.390.490.23-0.190.510.390.190.80.270.40.43
0.630.480.50.110.660.180.55-0.95-0.640.670.980.60.980.590.570.840.610.070.460.630.710.060.690.630.62
0.550.680.80.110.160.910.65-0.09-0.060.10.260.630.140.70.470.340.260.220.620.470.231.00.320.520.57
0.890.650.120.660.160.420.76-0.5-0.890.880.660.780.780.480.850.830.790.780.630.890.990.10.980.90.87
0.730.880.630.180.910.420.86-0.06-0.410.410.340.830.270.580.710.560.510.480.850.730.460.890.570.70.73
0.930.980.520.550.650.760.86-0.35-0.790.810.641.00.630.640.950.870.860.610.970.970.790.610.870.90.89
-0.48-0.27-0.56-0.95-0.09-0.5-0.06-0.350.41-0.45-0.93-0.41-0.92-0.56-0.36-0.7-0.350.1-0.25-0.44-0.55-0.05-0.52-0.48-0.48
-0.8-0.73-0.03-0.64-0.06-0.89-0.41-0.790.41-0.95-0.64-0.81-0.73-0.27-0.84-0.87-0.88-0.65-0.75-0.9-0.88-0.01-0.9-0.79-0.75
0.780.760.140.670.10.880.410.81-0.45-0.950.650.820.740.380.920.890.940.60.790.910.860.070.890.760.71
0.70.570.610.980.260.660.340.64-0.93-0.640.650.690.980.640.610.880.610.10.550.690.710.220.720.70.69
0.940.980.530.60.630.780.831.0-0.41-0.810.820.690.680.660.950.890.870.590.960.970.810.590.880.910.9
0.730.540.460.980.140.780.270.63-0.92-0.730.740.980.680.580.650.90.640.230.520.730.810.090.790.730.71
0.710.620.760.590.70.480.580.64-0.56-0.270.380.640.660.580.590.550.540.270.530.570.580.680.590.710.73
0.890.920.390.570.470.850.710.95-0.36-0.840.920.610.950.650.590.880.920.670.920.970.850.440.910.860.84
0.850.810.490.840.340.830.560.87-0.7-0.870.890.880.890.90.550.880.820.410.820.930.840.30.890.830.81
0.80.850.230.610.260.790.510.86-0.35-0.880.940.610.870.640.540.920.820.590.850.890.810.230.850.780.75
0.730.53-0.190.070.220.780.480.610.1-0.650.60.10.590.230.270.670.410.590.490.680.760.170.760.740.72
0.80.990.510.460.620.630.850.97-0.25-0.750.790.550.960.520.530.920.820.850.490.910.650.60.750.760.75
0.940.920.390.630.470.890.730.97-0.44-0.90.910.690.970.730.570.970.930.890.680.910.90.420.950.920.9
0.930.690.190.710.230.990.460.79-0.55-0.880.860.710.810.810.580.850.840.810.760.650.90.160.990.940.92
0.490.660.80.061.00.10.890.61-0.05-0.010.070.220.590.090.680.440.30.230.170.60.420.160.270.470.51
0.960.780.270.690.320.980.570.87-0.52-0.90.890.720.880.790.590.910.890.850.760.750.950.990.270.960.94
1.00.820.40.630.520.90.70.9-0.48-0.790.760.70.910.730.710.860.830.780.740.760.920.940.470.961.0
0.990.820.430.620.570.870.730.89-0.48-0.750.710.690.90.710.730.840.810.750.720.750.90.920.510.941.0
Click cells to compare fundamentals

Foghorn Therapeutics Account Relationship Matchups

Foghorn Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets22.3M255.6M519.8M404.9M285.9M280.8M
Short Long Term Debt Total16.6M82.0M58.3M51.5M45.1M47.8M
Other Current Liab450K5.2M2.6M5.0M(84K)(79.8K)
Total Current Liabilities12.7M18.8M48.7M336.8M58.4M87.8M
Total Stockholder Equity(88.0M)146.2M96.9M112K(77.2M)(73.3M)
Net Tangible Assets(88.0M)146.2M96.9M112K128.8K122.4K
Property Plant And Equipment Net3.7M62.3M56.1M49.4M42.9M39.7M
Net Debt1.6M(10.8M)(42.8M)(294.3M)(35.3M)(37.0M)
Retained Earnings(94.1M)(162.9M)(264.3M)(373.1M)(471.6M)(448.0M)
Accounts Payable3.4M3.7M3.8M5.4M6.3M4.5M
Cash15.0M92.8M101.1M345.8M80.3M123.8M
Non Current Assets Total5.5M64.9M60.2M59.1M45.7M43.6M
Non Currrent Assets Other11K842K2.4M8.0M2.8M2.7M
Other Assets1.7M2.6M4.1M4.1M1.00.95
Cash And Short Term Investments15.0M185.8M154.3M345.8M234.1M178.7M
Common Stock Shares Outstanding36.8M36.8M37.2M41.6M42.0M39.2M
Liabilities And Stockholders Equity22.3M255.6M519.8M404.9M285.9M280.8M
Non Current Liabilities Total97.7M90.6M374.2M68.0M304.7M185.9M
Capital Lease Obligations1.5M62.3M58.3M51.5M45.1M40.1M
Other Current Assets1.4M9.8M5.3M5.6M6.1M5.2M
Other Stockholder Equity6.1M309.1M361.1M377.2M395.2M266.4M
Total Liab110.4M109.4M422.9M404.8M363.1M273.7M
Net Invested Capital(72.9M)165.8M96.9M112K(77.2M)(73.3M)
Property Plant And Equipment Gross3.7M19.5M61.4M58.0M54.9M36.6M
Total Current Assets16.9M190.7M459.6M345.8M240.2M237.1M
Accumulated Other Comprehensive Income(86.6M)(7K)(10K)(4.0M)(826K)(867.3K)
Net Working Capital4.2M171.8M410.9M296.2M181.7M202.0M
Property Plant Equipment3.7M62.3M56.1M49.4M56.8M38.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Foghorn Stock Analysis

When running Foghorn Therapeutics' price analysis, check to measure Foghorn Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foghorn Therapeutics is operating at the current time. Most of Foghorn Therapeutics' value examination focuses on studying past and present price action to predict the probability of Foghorn Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foghorn Therapeutics' price. Additionally, you may evaluate how the addition of Foghorn Therapeutics to your portfolios can decrease your overall portfolio volatility.